NCT07557888尚未招募不适用
A Prospective Clinical Study on the Efficacy and Safety of Bacterial Lysate (OM-85) Combined With Antihistamines in the Treatment of Chronic Spontaneous Urticaria (CSU): A Single-Centre, Observational, Cohort Study
The Fourth Affiliated Hospital of Zhejiang University School of Medicine1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2026年5月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 132
- 试验地点
- 1
研究概览
简要总结
A Prospective Clinical Study on the Efficacy and Safety of Bacterial Lysate (OM-85) Combined with Antihistamines in the Treatment of Chronic Spontaneous Urticaria (CSU): A Single-Centre, Observational, Cohort Study
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The participants were fully informed of the purpose, procedure and risks of the study and voluntarily signed the informed consent form.
- •Aged 18 to 65 (inclusive), no gender restrictions.
- •Meets the CSU diagnostic criteria, with a disease duration of ≥6 weeks.
- •Antihistamine resistance: Regular use of a standard dose (as recommended in the package leaflet) of a second-generation H1 antihistamine (e.g. desloratadine 5 mg, levocetirizine 5 mg, etc.) for at least 2 weeks prior to screening, but with symptoms still not effectively controlled. Defined as: a UAS7 score of ≥7 within 7 days prior to the screening visit (V1) and baseline visit (V2).
- •Agree to maintain the type and dose of the baseline antihistamine throughout the trial.
- •Agree not to consume any products that may significantly affect the gut microbiota during the trial (such as yoghurt containing probiotics, or probiotic/prebiotic supplements).
- •At the baseline visit, the treatment regimen was clearly defined, and exposure status (OM-85 exposure group or non-exposure group) could be determined based on actual prescriptions and medication records.
排除标准
- •Special types of urticaria: These primarily include physical urticaria (such as artificial urticaria, cold contact urticaria and cholinergic urticaria), urticarial vasculitis, and angioedema caused by hereditary or acquired C1 esterase inhibitor deficiency;
- •Systemic use of glucocorticoids (oral or injectable) within the four weeks prior to screening;
- •Exclude patients who have used immunosuppressants (such as cyclosporine, methotrexate, or Tripterygium wilfordii) within the previous four weeks;
- •Exclude patients who have used biologics (such as omazulimab, dupilumab, etc.) within the previous three months;
- •Exclude those who have used bacterial lysates (such as Panfuxu or Pidomod) or received vaccinations within the past three months;
- •Key exclusion criteria for the microbiome study: use of oral or intravenous antibiotics within the four weeks prior to screening, or continuous use of probiotic supplements for more than one week.
- •Patients with severe systemic autoimmune diseases (such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, etc.) may interfere with the assessment of immune mechanisms;
- •A history of serious liver, kidney, heart, lung or blood disorders, or malignant tumours;
- •Individuals known to be allergic to bacterial lysates and their excipients.
- •Special populations: pregnant or breastfeeding women, or participants of childbearing age who do not intend to use contraception during the trial.
- •Other: Participants who have taken part in other clinical trials involving medicinal products within the past 30 days; or where the investigator considers that there is poor compliance, a mental health condition, or any other circumstance rendering the participant unsuitable for the trial.
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A Comparative Study of Papacarie, V-Carie-Solve, and Conventional Methods for Caries Removal in Primary MolarsCTRI/2025/12/098862Dr. Neha Battulwar66
招募中
不适用
Microbiological Evaluation of the Effectiveness of Different Surface Decontamination Protocols for Dental ImplantsPeriimplant DiseasesDental Implant FailureDental Implant ComplicationsNCT07529444University of Zagreb90
尚未招募
不适用
Testing the Effect of a Skincare Product on Melasma in Healthy IndividualsCTRI/2024/12/078257Glenmark Pharmaceuticals Ltd.36
Enrolling By Invitation
2 期
Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus DiseaseNCT07372781Beijing Chest Hospital24
尚未招募
1/2 期
To compare the antimicrobial efficacy of liquorice and chlorhexidine (1%) gel as cavity disinfectants in deciduous molarsCTRI/2024/02/063000DR WAJIHA KHAN84